| | | | |
Item 1(a) | | Name of Issuer. |
| |
| | The name of the issuer is Immatics N.V. (the “Issuer”). |
| |
Item 1(b) | | Address of Issuer’s Principal Executive Offices. |
| |
| | The Issuer’s principal executive office is located at Paul-Ehrlich-Straße 15, 72076 Tübingen, Germany. |
| |
Item 2(a) | | Name of Person Filing. |
| |
| | This Amendment No. 2 to Schedule 13G is being jointly filed by ATHOS KG, AT Impf GmbH and Thomas Maier, each of the foregoing, a “Reporting Person,” and collectively, the “Reporting Persons”. The sole member of AT Impf GmbH is ATHOS KG and, as a result, ATHOS KG is deemed to be the beneficial owner of the securities held by AT Impf GmbH. Thomas Maier is the general partner (komplementär) of ATHOS KG. The limited partners (kommanditisten) of ATHOS KG are members of the families of Thomas and Andreas Strüngmann. The Reporting Persons have entered into a Joint Filing Agreement, dated August 16, 2023, which was attached as Exhibit 1 to Schedule 13G filed by the Reporting Persons, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act. |
| |
Item 2(b) | | Address of Principal Business Office or, if none, Residence. |
| |
| | The address of the principal business office of each of the Reporting Persons is Bergfeldstraße 9 83607 Holzkirchen. |
| |
Item 2(c) | | Citizenship. |
| |
| | ATHOS KG is a German limited partnership (Kommanditgesellschaft); AT Impf GmbH is a German limited liability company (Gesellschaft mit beschränkter Haftung); and Mr. Maier is a citizen of Germany. |
| |
Item 2(d) | | Title of Class of Securities. |
| |
| | Ordinary Shares, nominal value €1.00 per share |
| |
Item 2(e) | | CUSIP No. |
| |
| | N44445109 |
| |
Item 3 | | If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: |
| |
| | Not applicable. |
| |
Item 4 | | Ownership. |
| |
| | Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
| | |
(a) | | Amount beneficially owned: | | See the responses to Item 9 on the attached cover pages. |
| | |
(b) | | Percent of class: | | See the responses to Item 11 on the attached cover pages, which were calculated based on 102,969,864 ordinary shares of the Issuer outstanding, based on 84,656,114 ordinary shares outstanding as of September 30, 2023 and after giving effect to an offering of 18,313,750 ordinary shares completed on January 22, 2024, as reported by the Issuer in its Forms 6-K filed with the Securities and Exchange Commission on November 14, 2023 and January 22, 2024. |